Gene · 1723
Papers2,016
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,016
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of S-phase arrest and mitochondrial dysfunction in complex III by DHODH inhibitors in tumorigenic TNBC cells. | Histochem Cell Biol | 2024 | 39557682 | PubTator, text mining | PubMed |
| A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation. | Sci Rep | 2024 | 39472491 | PubTator, text mining | PubMed |
| Synthesis, XRD structural analysis and theoretical studies of a potential inhibitor against rheumatoid arthritis (RA). | Acta Crystallogr C Struct Chem | 2024 | 39450509 | PubTator, text mining | PubMed |
| A mild skeletal phenotype with overlapping features of Miller syndrome and functional characterisation of two new variants of human dihydroorotate dehydrogenase. | Heliyon | 2024 | 39430512 | PubTator, text mining | PubMed |
| The DHODH inhibitor teriflunomide impedes cell proliferation and enhances chemosensitivity to daunorubicin (DNR) in T-cell acute lymphoblastic leukemia. | Ann Hematol | 2024 | 39377943 | PubTator, text mining | PubMed |
| Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity. | Antiviral Res | 2024 | 39306285 | PubTator, text mining | PubMed |
| Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis. | Biochem Biophys Res Commun | 2024 | 39303526 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction-Evoked DHODH Acetylation is Involved in Renal Cell Ferroptosis during Cisplatin-Induced Acute Kidney Injury. | Adv Sci (Weinh) | 2024 | 39303219 | PubTator, text mining | PubMed |
| circE2F1-encoded peptide inhibits circadian machinery essential for nucleotide biosynthesis and tumor progression via repressing SPIB/E2F1 axis. | Int J Biol Macromol | 2024 | 39288851 | PubTator, text mining | PubMed |
| Identification of isoquinolinone DHODH inhibitor isosteres. | Bioorg Med Chem Lett | 2024 | 39284456 | PubTator, text mining | PubMed |
| Engineering Biodegradable Hollow Silica/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the "Ferroptosis Storm". | ACS Nano | 2024 | 39226614 | PubTator, text mining | PubMed |
| Employing a synergistic bioinformatics and machine learning framework to elucidate biomarkers associating asthma with pyrimidine metabolism genes. | Respir Res | 2024 | 39217320 | PubTator, text mining | PubMed |
| Metabolic Plasticity of Glioblastoma Cells in Response to DHODH Inhibitor BAY2402234 Treatment. | Metabolites | 2024 | 39195509 | PubTator, text mining | PubMed |
| Radiosynthesis of [18F]brequinar for in vivo PET imaging of hDHODH for potential studies of acute myeloid leukemia and cancers. | RSC Med Chem | 2024 | 39149561 | PubTator, text mining | PubMed |
| CD44-hyaluronan mediating endocytosis of iron-platinum alloy nanoparticles induces ferroptotic cell death in mesenchymal-state lung cancer cells with tyrosine kinase inhibitor resistance. | Acta Biomater | 2024 | 39067646 | PubTator, text mining | PubMed |
| CACTI: an in silico chemical analysis tool through the integration of chemogenomic data and clustering analysis. | J Cheminform | 2024 | 39049122 | PubTator, text mining | PubMed |
| Targeting ferroptosis: a new therapeutic opportunity for kidney diseases. | Front Immunol | 2024 | 39021564 | PubTator, text mining | PubMed |
| Detection of a Mitochondrial Fragmentation and Integrated Stress Response Using the Cell Painting Assay. | J Med Chem | 2024 | 39018123 | PubTator, text mining | PubMed |
| Structure-aware dual-target drug design through collaborative learning of pharmacophore combination and molecular simulation. | Chem Sci | 2024 | 38994407 | PubTator, text mining | PubMed |
| Teriflunomide/leflunomide synergize with chemotherapeutics by decreasing mitochondrial fragmentation via DRP1 in SCLC. | iScience | 2024 | 38993482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1723/papers?page=11